← All compounds

Peptides Immune Support

PNC-27

PNC27

p53-derived peptide researched for selective anti-tumor activity; experimental.

Pharmacokinetic summary

Model tier: Simple (t½ + F, Tmax estimated)
Half-life: 0.0 days
Bioavailability: 40%
Typical dose: 5–20 mg